• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
FDMT

FDMT

4D Molecular Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD9.53

+0.26 (+2.80%)

Rating:C+

Company Profile

CEO

David H. Kirn

IPO Date

2020-12-11

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$9.28

Prev. Close

$9.27

Day Low

$8.97

Day High

$9.65

52W Low

$3.68

52W High

$12.34

Market Cap

$0.50B

Volume

0.91M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
Analyst Consensus
Buy

Strong Buy

0

Buy

10

Hold

3

Sell

1

Strong Sell

0

Analyst Grades
DateFirmPreviousNew GradeAction
20 Mar 2026HC Wainwright & Co.BuyBuymaintain
19 Mar 2026RBC CapitalOutperformOutperformmaintain
19 Mar 2026Chardan CapitalBuyBuymaintain
18 Dec 2025
Chardan Capital
Buy
Buy
maintain
11 Nov 2025BarclaysOverweightOverweightmaintain
11 Nov 2025Chardan CapitalBuyBuymaintain
11 Nov 2025RBC CapitalOutperformOutperformmaintain
21 Oct 2025RBC CapitalOutperformOutperformmaintain
12 Aug 2025Roth CapitalBuyBuymaintain
12 Aug 2025Chardan CapitalBuyBuymaintain